Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/01/011150
CTRI/2018/01/011150
Recruiting
未知

A prospective, multi-centric study to investigate the plaque characteristics and natural history of lesions in the non-culprit vessels in young Indian patients (less than 45 yrs) with ACS undergoing PCI by Optical Coherence Tomography (OCT) imaging - ACS-OCT

Batra Hospital and Medical Research Centre0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I248- Other forms of acute ischemic heart diseaseHealth Condition 2: null- young indian acute coronary syndrome patients who are less than 45 years of age

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I248- Other forms of acute ischemic heart diseaseHealth Condition 2: null- young indian acute coronary syndrome patients who are less than 45 years of age
Sponsor
Batra Hospital and Medical Research Centre
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Batra Hospital and Medical Research Centre

Eligibility Criteria

Inclusion Criteria

  • •Patient is more than or equals to 18 and less than or equals to 45 years of age and going for PCI of the culprit lesion (more than 90 per cent diameter stenosis)
  • •At least more than or equals to 1 de novo lesions in a native coronary segment with a visually estimated diameter stenosis between more than or equals to 40 per cent and less than 90 per cent
  • •Patient has documented ACS ( unstable angina, NSTEMI or STEMI within the previous 72 hours)
  • •Patient demonstrates a left ventricular ejection fraction (LVEF) of more than or equals to 40 per cent as measured prior to enrollment
  • •Patient understands and agrees to comply with all specified study requirements and provides written Informed Consent to this effect

Exclusion Criteria

  • •The patient has a life expectancy of less than 24 months due to another medical condition
  • •Patient exhibits cardiogenic shock (systolic pressure less than 80mm Hg and PCWP more than 20mm Hg or cardiac index less than 1\.8 liters per minute per meter square or intra\-aortic balloon pump or intravenous inotropes are needed to maintain a systolic pressure more than 80 mm Hg) for any time within 24 hours prior to index procedure.
  • •Patient demonstrates evidence of acute or chronic renal dysfunction (serum creatinine more than 2\.0 mg per dl or 177 μmol per l)
  • •Planned cardiac surgery procedure less than or equals to 6 months post\-index procedure.
  • •Cerebrovascular accident (CVA) including stroke or TIA within previous 3 months
  • •Patient has contraindication to Aspirin clopidogrel, prasugrel or ticagrelor
  • •Female of childbearing potential with a positive pregnancy test within 7 days before the index procedure, or lactating, or intends to become pregnant during the 6 months post index procedure
  • •Patient that in the opinion of the investigator is not clinically appropriate for OCT evaluation
  • •Patient in whom the primary culprit lesion requiring PCI have one of the following characteristics â??
  • •vessel is moderately or severely calcified, by visual estimate

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Milk Of Magnesia+Liquid Paraffin+Sodium Picosulfate In The Management Of Constipation Post Ano-Rectal Surgery PatientsHealth Condition 1: K590- Constipation
CTRI/2024/07/070750Abbott India Limited
Active, not recruiting
Not Applicable
An observational study to collect data on microbial diversity of human gut/Intestine of Indian populatio
CTRI/2016/03/006716TATA Chemicals1,000
Completed
Not Applicable
An Observational study to evaluate the Prevalence of Hypogonadism in Indian male patients suffering from T2DM with or wothout Obesity.Health Condition 1: E35- Disorders of endocrine glands in diseases classified elsewhere
CTRI/2021/04/032544Abbott Healthcare Pvt Ltd600
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-BEActelion Pharmaceuticals Ltd.200
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.Clostridium difficile-associated diarrhea (CDAD)MedDRA version: 20.0Level: LLTClassification code 10012734Term: Diarrhea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10054236Term: Clostridium difficile infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10012748Term: Diarrhoea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2015-004805-17-ESActelion Pharmaceuticals Ltd.1